These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38012539)
21. Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings. Mitani Y; Li J; Weber RS; Lippman SL; Flores ER; Caulin C; El-Naggar AK Am J Pathol; 2011 Jul; 179(1):391-9. PubMed ID: 21703418 [TBL] [Abstract][Full Text] [Related]
22. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma. Pokorna Z; Hrabal V; Tichy V; Vojtesek B; Coates PJ Front Oncol; 2022; 12():924354. PubMed ID: 35912167 [TBL] [Abstract][Full Text] [Related]
23. Comparison of p63 and p40 (ΔNp63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors. Owosho AA; Aguilar CE; Seethala RR Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):501-8. PubMed ID: 26230372 [TBL] [Abstract][Full Text] [Related]
24. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma. Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756 [TBL] [Abstract][Full Text] [Related]
25. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823 [TBL] [Abstract][Full Text] [Related]
26. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast. Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948 [TBL] [Abstract][Full Text] [Related]
27. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis. Vogt AP; Cohen C; Siddiqui MT Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777 [TBL] [Abstract][Full Text] [Related]
28. ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma. Katoh I; Tsukinoki K; Hata RI; Kurata SI Neoplasia; 2023 Nov; 45():100938. PubMed ID: 37778252 [TBL] [Abstract][Full Text] [Related]
29. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis. Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901 [TBL] [Abstract][Full Text] [Related]
30. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. Karni-Schmidt O; Castillo-Martin M; Shen TH; Gladoun N; Domingo-Domenech J; Sanchez-Carbayo M; Li Y; Lowe S; Prives C; Cordon-Cardo C Am J Pathol; 2011 Mar; 178(3):1350-60. PubMed ID: 21356385 [TBL] [Abstract][Full Text] [Related]
31. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas. Chen YK; Hsue SS; Lin LM Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414 [TBL] [Abstract][Full Text] [Related]
32. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63. Helton ES; Zhang J; Chen X Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962 [TBL] [Abstract][Full Text] [Related]
33. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma. Rooper L; Sharma R; Bishop JA Head Neck Pathol; 2015 Mar; 9(1):79-84. PubMed ID: 24969705 [TBL] [Abstract][Full Text] [Related]
34. A study of ΔNp63 expression in lung non-small cell carcinomas. Nonaka D Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298 [TBL] [Abstract][Full Text] [Related]
35. Keratin Expression Patterns in Stromal Cells of Benign Sclerosing Lesions of the Breast: A Potential Diagnostic Pitfall. Oh EY; Collins LC Arch Pathol Lab Med; 2015 Sep; 139(9):1143-8. PubMed ID: 25989286 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Werling RW; Hwang H; Yaziji H; Gown AM Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930 [TBL] [Abstract][Full Text] [Related]
37. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671 [TBL] [Abstract][Full Text] [Related]
38. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours. D'Alfonso TM; Ross DS; Liu YF; Shin SJ J Clin Pathol; 2015 Jul; 68(7):516-21. PubMed ID: 25795733 [TBL] [Abstract][Full Text] [Related]
39. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253 [TBL] [Abstract][Full Text] [Related]
40. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]